Tandem Diabetes Care Files Q3 2024 10-Q
Ticker: TNDM · Form: 10-Q · Filed: 2024-11-06T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, diabetes-care
TL;DR
Tandem Diabetes Care's Q3 2024 10-Q is in. Check financials.
AI Summary
Tandem Diabetes Care, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter of 2024. Key financial figures and business segments are presented, reflecting the company's ongoing activities in the diabetes care market.
Why It Matters
This filing provides investors and stakeholders with the latest financial health and operational performance of Tandem Diabetes Care, crucial for understanding the company's trajectory in the medical device sector.
Risk Assessment
Risk Level: medium — The company operates in the highly regulated medical device industry, facing competition and potential product development risks.
Key Numbers
- 2024 Q3 — Reporting Period (Indicates the specific quarter for which financial data is reported.)
- 12/31 — Fiscal Year End (Specifies the end date of the company's fiscal year.)
Key Players & Entities
- TANDEM DIABETES CARE INC (company) — Filer
- San Diego (location) — Business Address City
- 20240930 (date) — Period of Report
- 20241106 (date) — Filed as of Date
FAQ
What is the primary business of Tandem Diabetes Care Inc.?
Tandem Diabetes Care Inc. operates in the Surgical & Medical Instruments & Apparatus industry, as indicated by SIC code 3841.
What is the filing date and reporting period for this 10-Q?
This 10-Q was filed on November 6, 2024, and reports on the period ending September 30, 2024.
Where is Tandem Diabetes Care Inc. headquartered?
The company's business and mailing address is located at 12400 High Bluff Drive, San Diego, CA 92130.
What is the SEC file number for Tandem Diabetes Care Inc.?
The SEC file number for Tandem Diabetes Care Inc. is 001-36189.
What is the fiscal year end for Tandem Diabetes Care Inc.?
Tandem Diabetes Care Inc.'s fiscal year ends on December 31.
From the Filing
0001438133-24-000201.txt : 20241106 0001438133-24-000201.hdr.sgml : 20241106 20241106161129 ACCESSION NUMBER: 0001438133-24-000201 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 81 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241106 DATE AS OF CHANGE: 20241106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 241431048 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 10-Q 1 tndm-20240930.htm 10-Q tndm-20240930 false 2024 Q3 0001438133 12/31 0.0289361 0.0088836 one xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure tndm:trading_day tndm:segment iso4217:CHF tndm:lawsuit 0001438133 2024-01-01 2024-09-30 0001438133 2024-11-01 0001438133 2024-09-30 0001438133 2023-12-31 0001438133 2024-07-01 2024-09-30 0001438133 2023-07-01 2023-09-30 0001438133 2023-01-01 2023-09-30 0001438133 us-gaap:CommonStockMember 2024-06-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001438133 us-gaap:RetainedEarningsMember 2024-06-30 0001438133 2024-06-30 0001438133 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001438133 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001438133 us-gaap:CommonStockMember 2024-09-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001438133 us-gaap:RetainedEarningsMember 2024-09-30 0001438133 us-gaap:CommonStockMember 2023-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001438133 us-gaap:RetainedEarningsMember 2023-12-31 0001438133 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0001438133 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001438133 us-gaap:CommonStockMember 2023-06-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001438133 us-gaap:RetainedEarningsMember 2023-06-30 0001438133 2023-06-30 0001438133 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001438133 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001438133 us-gaap:CommonStockMember 2023-09-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001438133 us-gaap:RetainedEarningsMember 2023-09-30 0001438133 2023-09-30 0001438133 us-gaap:CommonStockMember 2022-12-31 0001438133 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001438133 us-gaap:RetainedEarningsMember 2022-12-31 0001438133 2022-12-31 0001438133 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001438133 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001438133 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0001438133 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001438133 tndm:InsulinPumpMember srt:MinimumMember 2024-01-01 2024-09-30 0001438133 tndm:Privat